Skip to main content

Want a detailed portfolio tracker?

Lisata Therapeutics (LSTA) P/E (2011 - 2026)

Lisata Therapeutics (LSTA) P/E from Mar 31, 2011 to Jul 20, 2026. The TTM Lisata Therapeutics (LSTA) P/E is -1.90. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Lisata Therapeutics (LSTA)

YearP/EChange
2026-1.90+95.10%
2025-0.98-21.57%
2024-1.24+21.94%
2023-1.02+268.60%
2022-0.28-84.87%
2021-1.83+86.76%
2020-0.98-341.72%
20190.41-29.49%
20180.57+1.42%
20170.57+24.03%
20160.46-70.36%
20151.54-109.61%
2014-16.03-44.72%
2013-29.00+78.74%
2012-16.23+14.67%
2011-14.15N/A

Comparison Lisata Therapeutics (LSTA) P/E with competitors

Lisata Therapeutics (LSTA) P/E is -1.90.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.09%
NBYStablecoin Development Corp0.00-100.23%
ENLVEnlivex Ltd0.07-103.93%
FGENFibroGen Inc0.24-112.61%
CHRSCoherus Biosciences Inc0.85-144.59%
FBIOFortress Biotech Inc0.95-149.87%
ORMPOramed Pharmaceuticals Inc1.50-178.99%
AGENAgenus Inc3.01-258.16%
INVAInnoviva Inc3.15-265.75%
VXRTVaxart Inc3.55-286.55%
CRMDCorMedix Inc3.63-290.68%
CVACCureVac N.V.4.45-333.63%
GLPGGalapagos NV4.86-355.35%
SRPTSarepta Therapeutics Inc4.88-356.56%
ABEOAbeona Therapeutics Inc5.39-383.13%
ABUSArbutus Biopharma Corp5.60-394.06%
ZVRAZevra Therapeutics Inc5.89-409.39%
SPROSpero Therapeutics Inc6.23-427.32%
CGENCompugen Ltd6.31-431.81%
RIGLRigel Pharmaceuticals6.87-461.14%
SLXNSilexion Therapeutics Corp7.30-483.42%
OMEROmeros Corporation9.26-586.57%
AUPHAurinia Pharmaceuticals Inc9.58-603.71%
PLXProtalix BioTherapeutics Inc10.89-672.35%
ACADAcadia Pharmaceuticals Inc11.73-716.36%
TBPHTheravance Biopharma Inc12.26-744.40%
ADMAAdma Biologics Inc12.42-752.60%
HRMYHarmony Biosciences Holdings Inc13.82-826.28%
SABSSAB Biotherapeutics Inc14.14-842.89%
NAGENiagen Bioscience Inc14.82-878.73%
INCYIncyte Corp15.82-931.51%
REGNRegeneron Pharmaceuticals Inc15.86-933.30%
PBYIPuma Biotechnology Inc17.32-1009.98%
CPRXCatalyst Pharmaceuticals Inc17.44-1016.48%
EXELExelixis Inc17.54-1021.66%
TGTXTG Therapeutics Inc18.97-1096.71%
MDXGMimedx Group Inc20.55-1180.08%
XOMAXOMA Royalty Corp22.87-1302.15%
ARGXArgen X SE24.30-1376.95%
CTMXCytomX Therapeutics Inc24.82-1404.44%
XOMAOXOMA Royalty Corp25.34-1431.97%
HALOHalozyme Therapeutics Inc25.62-1446.62%
XOMAPXOMA Royalty Corp25.67-1449.06%
VRTXVertex Pharmaceuticals Inc27.99-1571.23%
RPRXRoyalty Pharma plc - Class A28.69-1607.64%
SLNOSoleno Therapeutics Inc29.02-1624.87%
ASNDAscendis Pharma A/S30.09-1681.11%
LGNDLigand Pharmaceuticals Inc - Class B37.91-2092.42%
APLSApellis Pharmaceuticals Inc39.02-2150.71%
BMRNBiomarin Pharmaceutical Inc42.21-2318.39%
KRYSKrystal Biotech Inc45.34-2482.97%
ONCBeiGene Ltd69.54-3754.61%
PHARPharming Group N.V.75.03-4042.88%
TECHBio-Techne Corp101.96-5458.30%
VCELVericel Corp109.92-5876.78%
ALNYAlnylam Pharmaceuticals Inc117.96-6299.52%
GMABGenmab140.29-7472.81%
TLXTelix Pharmaceuticals Ltd162.15-8621.75%
CORTCorcept Therapeutics Inc212.86-11286.47%